The Demography of Reaching 111: Secrets of Extreme Longevity
The Late-Life Mortality Deceleration Plateau
In standard human biology, mortality risk doubles roughly every 7 to 8 years between ages 30 and 85 (described by the Gompertz law). However, landmark demographic studies led by Elisabetta Barbi and James Vaupel (Science, 2018) analyzing thousands of supercentenarians showed that around ages 105 to 110, the curve levels off. At age 111, mortality hazard ceases exponential acceleration and settles into a plateau of ~45% to 52% per year—effectively an annual coin flip.
Compression of Morbidity & Genetic Buffers
As reported by families of centenarians and verified by the New England Centenarian Study, supercentenarians like 111-year-olds do not simply age slower—they exhibit dramatic compression of morbidity. Over 90% live independently without chronic cardiovascular or neurodegenerative disability well into their late 90s, enabled by protective genotypes (such as FOXO3A, ADIPOQ, and low ApoE ε4 carriage) coupled with low chronic systemic inflammation (inflammaging resistance).